查詢結果分析
相關文獻
- Acute Renal Failure Caused by Rifampicin Re-exposure with 10-Year of Interval
- Hemolytic-Uremic Syndrome Following Excessive Heroin Inhalation
- Mycoplasma Pneumonia Complicated with Cold Agglutinin Hemolysis, Ischemic Stroke, and Acute Kidney Injury in a Middle-aged Woman with Type II Diabetes: A Case Report and Literature Review
- 高雄市肺結核患者與非患者對肺結核知識、態度與預防行為之比較
- 某醫學中心79∼83年肺結核住院病患之研究
- 胸腔內科護理人員對肺結核病患的照顧意願及其影響因素之探討
- 急性腎衰竭之處理:一般原則
- 急性腎衰竭的傳統透析療法
- 急性腎衰竭之連續性腎臟替代法
- Acute Pyelonephritis Complicated with Acute Renal Failure: A Case Report
頁籤選單縮合
題 名 | Acute Renal Failure Caused by Rifampicin Re-exposure with 10-Year of Interval=間隔十年再次使用立汎黴素造成的急性腎衰竭 |
---|---|
作 者 | 蔡崇麟; 李志雄; 莊峰榮; 許國泰; | 書刊名 | 長庚醫學 |
卷 期 | 24:11 2001.11[民90.11] |
頁 次 | 頁729-733 |
分類號 | 418.284 |
關鍵詞 | 立汎黴素; 溶血性貧血; 急性腎衰竭; 肺結核; Rifampicin; Hemolytic anemia; Acute renal failure; Tuberculosis; |
語 文 | 英文(English) |
中文摘要 | 53歲女性在經過十年後因復發性肺結核而再次接受立汎黴素治療。病患在服下第一個劑量後,發生嚴重的溶血性貧血和乏尿性急性腎衰竭而需要暫時性血液透析治療。其急性的臨床過程與立汎黴素導致的急性腎衰竭相吻合。此病人的腎功能在停用立汎黴素和經過暫時性血液透析治療後完全恢復。由於腎臟切片和抗立汎黴素抗體並不能提供一個確切的診斷,我們必須強調臨床診斷和完整病史詢問對於診斷立汎黴素導致的急性腎衰竭的重要性。停藥後再次服用是一個重要的因素。我們這個病人停藥的間隔甚至長達十年之久。由於立汎黴素導致的急性腎衰竭預後通常都良好,因此再次使用立汎黴素來治療復發性肺結核不應輕言放棄。但我們必須將這一個少見但潛在性有生命威脅的副作用牢記在心。 |
英文摘要 | A 53-year-old woman was treated for recurrent pulmonary tuberculosis with reintroduction of rifampicin after a medication-free interval of 10 years. After taking the first dose, she developed severe hemolytic anemia and oliguric acute renal failure and required temporary hemodialysis. The fulminant clinical course was compatible with rifampicin-induced acute renal failure. The renal function of this patient completely recovered after discontinuation of rifampicin and temporary hemodialysis. Since renal biopsy and anti-rifampicin antibodies cannot offer a definite diagnosis of rifampicin-induced acute renal failure, we must emphasize the importance of a clinical diagnosis of rifampicin-induced acute renal failure and complete history taking. Re-exposure is a critical factor. In this case, the rifampicin-free interval was as long as 10 years. Because of the feasible prognosis, reintroduction of rifampicin for recurrent pulmonary tuberculosis should not be abandoned, but the infrequent and life-threatening side effects should be kept in mind. |
本系統中英文摘要資訊取自各篇刊載內容。